2025-522246-43-00招募中1 期
Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 124
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Research team
Scientific
Blau Farmaceutica S.A.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16
已完成
1 期
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-068214972023-508371-36-00Pfizer Inc.6
招募中
1 期
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food2024-519615-34-00Boehringer Ingelheim International GmbH17
招募中
1 期
A study in healthy men to test how well different doses of BI 3776528 are tolerated2024-515222-92-00Boehringer Ingelheim International GmbH118
已完成
1 期
A study in healthy men to test how well different doses of BI 3731579 are tolerated2023-510318-25-00Boehringer Ingelheim International GmbH64